Irinotecan hydrochloride liposome injection (LY01610)

irinotecan hydrochloride liposome injection · Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Irinotecan hydrochloride liposome injection (LY01610), covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer [Phase 2]

See pricing